Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
1.06
Oct 30 • 2:51 PM ET Dollar change-0.06 Percentage change(-5.79%)
Index
-
Market Cap
70.86M
Enterprise Value
3.36M
Income
-16.34M
Sales
0.35M
Book/sh
1.03
Cash/sh
1.02
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
43
IPO
Mar 25, 1992
P/E
-
Forward P/E
-
PEG
-
P/S
202.46
P/B
1.03
P/C
1.04
P/FCF
-
EV/EBITDA
-
EV/Sales
9.60
Quick Ratio
17.82
Current Ratio
18.56
Debt/Eq
0.01
LT Debt/Eq
0.01
Option/Short
Yes / Yes
EPS (ttm)
-0.26
EPS next Y
-0.32
EPS next Q
-0.08
EPS this Y
-5.17%
EPS next Y
-4.92%
EPS next 5Y
8.80%
EPS past 3/5Y
45.91% 25.94%
Sales past 3/5Y
- -
EPS Y/Y TTM
53.95%
Sales Y/Y TTM
-
EPS Q/Q
12.62%
Sales Q/Q
-
Insider Own
9.14%
Insider Trans
0.00%
Inst Own
17.28%
Inst Trans
-19.62%
ROA
-30.68%
ROE
-32.91%
ROIC
-23.52%
Gross Margin
-198.84%
Oper. Margin
-5348.84%
Profit Margin
-4722.25%
SMA20
3.57%
SMA50
-15.34%
SMA200
-42.87%
Trades
Shs Outstand
67.16M
Shs Float
61.03M
52W High
2.86 -63.04%
52W Low
0.93 13.45%
Volatility
7.08% 6.34%
ATR (14)
0.07
RSI (14)
44.80
Beta
1.06
Rel Volume
1.89
Avg Volume
699.56K
Volume
1,101,430
Perf Week
8.34%
Perf Month
-12.08%
Perf Quarter
-40.39%
Perf Half Y
-49.76%
Perf YTD
-47.25%
Perf Year
-51.15%
Perf 3Y
-6.63%
Perf 5Y
-85.41%
Perf 10Y
-99.04%
Prev Close
1.12
Price
1.06
Change %
-5.79%
Consensus
Strong Buy
Avg. Price Target
$5.38
Implied Upside
+409.9%
Analysts5incl. previous ratings
Rating Distribution5 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 23, 2026Initiated
CCitizens
Mkt Outperform$2.50+136.9%
Sep 11, 2026Resumed
RILY logoRB. Riley Securities
Buy$4+279.1%
Feb 10, 2026Initiated
RILY logoRB. Riley Securities
Buy$5+373.9%
Dec 03, 2025Initiated
RRoth Capital
Buy$5.50+421.3%
Jan 13, 2020Reiterated
HH.C. Wainwright
Buy$12 → $26+2,364.2%
Dec 24, 2019Reiterated
HH.C. Wainwright
Buy$10 → $12+1,037.3%
Jan 31, 2018Initiated
LLadenburg Thalmann
Buy$1.75+65.9%
Microbot Medical, Inc. is a medical device company, which engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
Co-FounderMr. Harel Gadot
Chief Financial OfficerMs. Rachel Vaknin
MScDr. Simon Sharon MBA
Chief Medical OfficerDr. Juan Diaz-Cartelle
Vice President of SalesMs. Christina Bailey